Loading clinical trials...
Loading clinical trials...
Face Study of the Effects of Needling Using the Straberi Epistamp for the Improvement of Fine Lines and Skin Laxity.
This pilot study will expand knowledge and application needling using the Epistamp device for the improvement of a new vitalized epidermal layer with new vibrant active cells, supported by more robust collagen and elastin fine lines, deep wrinkles, and collagen production.
This pilot study will expand the knowledge and application needling using the Epistamp device and its benefits for improving the appearance of fine lines, deep wrinkles, and collagen production. The pilot aims to objectively measure skin quality using the Derma Scan, photographs and provide objective data showing improvement by way of the Universal Skincare Institute Blood Flow Scale.
Age
21 - 65 years
Sex
ALL
Healthy Volunteers
Yes
Lavish
New York, New York, United States
Start Date
December 23, 2022
Primary Completion Date
June 30, 2023
Completion Date
October 12, 2023
Last Updated
December 6, 2023
30
ACTUAL participants
Straberi Epistamp Microneedling Treatment
DEVICE
Lead Sponsor
Universal Skincare Institute
Collaborators
NCT07187297
NCT07255261
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions